2-73450771-G-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378454.1(ALMS1):​c.4244G>C​(p.Gly1415Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.258 in 1,607,392 control chromosomes in the GnomAD database, including 66,432 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 15837 hom., cov: 31)
Exomes 𝑓: 0.24 ( 50595 hom. )

Consequence

ALMS1
NM_001378454.1 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -2.83
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.505922E-7).
BP6
Variant 2-73450771-G-C is Benign according to our data. Variant chr2-73450771-G-C is described in ClinVar as [Benign]. Clinvar id is 379229.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.766 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALMS1NM_001378454.1 linkc.4244G>C p.Gly1415Ala missense_variant Exon 8 of 23 ENST00000613296.6 NP_001365383.1
ALMS1NM_015120.4 linkc.4244G>C p.Gly1415Ala missense_variant Exon 8 of 23 NP_055935.4 Q8TCU4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALMS1ENST00000613296.6 linkc.4244G>C p.Gly1415Ala missense_variant Exon 8 of 23 1 NM_001378454.1 ENSP00000482968.1 Q8TCU4-1

Frequencies

GnomAD3 genomes
AF:
0.399
AC:
58505
AN:
146478
Hom.:
15774
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.773
Gnomad AMI
AF:
0.286
Gnomad AMR
AF:
0.385
Gnomad ASJ
AF:
0.181
Gnomad EAS
AF:
0.00808
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.258
Gnomad NFE
AF:
0.248
Gnomad OTH
AF:
0.350
GnomAD3 exomes
AF:
0.268
AC:
66158
AN:
247308
Hom.:
12193
AF XY:
0.250
AC XY:
33493
AN XY:
134160
show subpopulations
Gnomad AFR exome
AF:
0.784
Gnomad AMR exome
AF:
0.412
Gnomad ASJ exome
AF:
0.171
Gnomad EAS exome
AF:
0.00620
Gnomad SAS exome
AF:
0.163
Gnomad FIN exome
AF:
0.233
Gnomad NFE exome
AF:
0.238
Gnomad OTH exome
AF:
0.246
GnomAD4 exome
AF:
0.243
AC:
355637
AN:
1460804
Hom.:
50595
Cov.:
42
AF XY:
0.239
AC XY:
173873
AN XY:
726718
show subpopulations
Gnomad4 AFR exome
AF:
0.781
Gnomad4 AMR exome
AF:
0.409
Gnomad4 ASJ exome
AF:
0.169
Gnomad4 EAS exome
AF:
0.0123
Gnomad4 SAS exome
AF:
0.167
Gnomad4 FIN exome
AF:
0.232
Gnomad4 NFE exome
AF:
0.237
Gnomad4 OTH exome
AF:
0.249
GnomAD4 genome
AF:
0.400
AC:
58633
AN:
146588
Hom.:
15837
Cov.:
31
AF XY:
0.394
AC XY:
28146
AN XY:
71466
show subpopulations
Gnomad4 AFR
AF:
0.773
Gnomad4 AMR
AF:
0.385
Gnomad4 ASJ
AF:
0.181
Gnomad4 EAS
AF:
0.00810
Gnomad4 SAS
AF:
0.164
Gnomad4 FIN
AF:
0.262
Gnomad4 NFE
AF:
0.248
Gnomad4 OTH
AF:
0.348
Alfa
AF:
0.220
Hom.:
3098
Bravo
AF:
0.415
TwinsUK
AF:
0.230
AC:
851
ALSPAC
AF:
0.233
AC:
898
ESP6500AA
AF:
0.738
AC:
2767
ESP6500EA
AF:
0.238
AC:
1956
ExAC
AF:
0.268
AC:
32390
Asia WGS
AF:
0.126
AC:
438
AN:
3478
EpiCase
AF:
0.233
EpiControl
AF:
0.238

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Gly1414Ala in exon 8 of ALMS1: This variant is not expected to have clinical s ignificance because it has been identified in 87.82% (1161/1322) of African chro mosomes by the 1000 Genomes Project (Phase 3; dbSNP rs6546837). -

Sep 22, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Alstrom syndrome Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Cardiovascular phenotype Benign:1
Dec 21, 2018
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.82
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.0020
DANN
Benign
0.10
DEOGEN2
Benign
0.0059
T;.;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.00028
N
LIST_S2
Benign
0.086
T;T;T
MetaRNN
Benign
8.5e-7
T;T;T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.23
T
Sift4G
Benign
0.80
T;T;T
Vest4
0.020
ClinPred
0.0067
T
GERP RS
-0.18
Varity_R
0.028
gMVP
0.017

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6546837; hg19: chr2-73677898; COSMIC: COSV52524671; COSMIC: COSV52524671; API